Flagship & Portfolio Company News - 2009

Archives
2008
2007
 2006
2005
2004
2003
2002
03/11/2010
Ze-gen Named Top 50 Greentech Startup

03/11/2010
VisEn Launches New VivoTag® 680 XL Fluorescence Molecular Imaging Label

03/10/2010
Acceleron Recognized by The Wall Street Journal as One of the Top 50 Venture-Backed Companies in the United States

03/04/2010
TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers

03/02/2010
Flagship highlighted in WSJ blog Venture Capital Dispatch for having three companies in MIT Technology Review TR50 Most Innovative Companies list

03/02/2010
Joule Named Among 50 Most Innovative Companies in the World

02/23/2010
MIT's Technology Review Unveils 2010 TR50 List of the World's Most Innovative Companies

02/23/2010
AVEO Pharma Sets IPO Terms

02/17/2010
Eleven Biotherapeutics Completes $35 Million Series A Funding to Advance Pipeline of Innovative Protein-Based Therapeutics

02/03/2010
LS9 Purchases Florida Site to Manufacture Renewable Petroleum

02/01/2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel®

01/29/2010
BG Medicine Files Registration Statement for Proposed Initial Public Offering

01/28/2010
VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms from Bayer Schering Pharma

01/27/2010
Joule Names Troy Campione Senior Vice President of Corporate Development

01/27/2010
BG Medicine Announces Receipt of CE Mark for its Galectin-3 Blood Test 01/27/2010

01/27/2010
LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production

01/21/2010
DSM and Novomer to Develop First CO2-based Resin for Coatings

01/20/2010
Joule Biotechnologies Secures Pilot Site for Renewable Solar Fuel

01/19/2010
Helicos BioSciences Announces the Sale of a Helicos® Genetic Analysis System to the Turku Centre for Biotechnology

01/19/2010
VisEn Launches New Cat B 680 FAST™ Fluorescence Molecular Imaging Agent

01/14/2010
BIND Biosciences, Inc. Closes $11M Series C Financing Round

01/11/2010
BIND Biosciences Appoints Scott Minick as President and CEO

01/08/2010
Mascoma Appoints William J. Brady as Chief Executive Officer

01/06/2010
Ensemble Discovery Initiates Collaboration with Pfizer to Develop Novel Drugs against Protein-Protein Interaction Targets

01/06/2010
T2 BioSystems Appoints Ken Toso Vice President, Product Development

12/31/2009
Novomer highlighted as #1 in GreanBeat's 2009’s top 9 forward-looking cleantech investments

12/22/2009
Acceleron Pharma Expands Management Team with Two New Appointments

12/16/2009
AVEO Pharmaceuticals Files Registration Statement for Initial Public Offering

12/14/2009
Novomer Expands Green Materials Commercialization With Kodak, RIT and NYSERDA

12/09/2009
Concert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board

12/08/2009
Acceleron Pharma Presents Findings of ACE-536, a Novel Red Blood Cell-Forming Agent, at the 51st Annual Meeting of the American Society of Hematology

11/23/2009
Receptos Completes $25M Series A Financing

11/19/2009
VisEn Launches New Osteosense® 800 and Vivotag® 800 Fluorescence Molecular Imaging Agents

11/17/2009
Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform

11/12/2009
VisEn Launches New Cat B 750 FAST™ Fluorescence Molecular Imaging Agent at American Heart Association Meeting

11/09/2009
Helicos BioSciences Provides Strategic Update

11/09/2009
Joule Reports Breakthrough in Renewable Diesel Production

11/09/2009
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV

11/06/2009
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post

10/29/2009
Selecta Co-Founder Named 2009 Mass High Tech All Star

10/21/2009
Seventh Sense Biosystems Receives Grand Challenges Explorations Grant for Innovative Global Health Research from Gates Foundation

10/06/2009
Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates

09/28/2009
Helicos Announces System Sale to Correlagen Diagnostics

09/24/2009
LS9 Secures $25 Million in Latest Round of Funding

09/23/2009
VisEn Medical Extends Fluorescence Molecular Tomography (FMT™) Product Line

09/23/2009
VisEn Launches Reninsense680 FAST Molecular Imaging Agent to Enable in vivo Imaging Readouts of Key Biomarkers in Hypertension and Renal Function

09/21/2009
Joule Biotechnologies Elects Graham Allison to Board of Directors

09/16/2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member

09/16/2009
Ze-gen, Inc Named a Global Cleantech 100 Clean Technology Company

09/16/2009
Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement

09/15/2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension

09/14/2009
Mascoma Announces Feedstock Processing and Lignin Supply Agreement with Chevron Technology Ventures

09/14/2009
Concert Pharmaceuticals Presents Clinical Results Demonstrating Reduced Drug-Drug Interactions with a Deuterium-Modified Compound

09/10/2009
Acceleron Pharma’s ACE-031 Increases Lean Body Mass in Phase 1 Single Dose Clinical Trial

09/08/2009
Helicos Sells Multiple HeliScope(TM) Sequencers to RIKEN Institute

09/03/2009
Helicos BioSciences Provides Q2 2009 Operating Highlights and Strategic Update

09/02/2009
Dr. David Okrongly Appointed CEO of Quanterix Corporation

09/02/2009
VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent

08/24/2009
Resolvyx Announces Positive Data from Phase 2 Clinical Trial of the Resolvin RX-10045 in Patients with Dry Eye Syndrome

08/18/2009
Novomer Raises $14M Series B Financing

08/13/2009
Massachusetts General Hospital Cancer Center Takes Delivery of a Helicos(TM) Genetic Analysis System

08/10/2009
Helicos BioSciences Announces the First Ever Single-Molecule View of Whole Human Genome

08/04/2009
Advanced Electron Beams Raises $14.2 Million From GE, Flagship Ventures & Others for Market Penetration and Development of New Energy-Efficient Manufacturing Applications

07/30/2009
VisEn Molecular Imaging Technology Enables Key Insights into Newly Discovered Biologic Pathway Published In Science

07/27/2009
Joule Biotechnologies Introduces Revolutionary Process for Producing Renewable Transportation Fuels

07/27/2009
Joule Biotechnologies Names Bill Sims President and CEO

07/21/2009
OSI Pharmaceuticals and AVEO Pharmaceuticals Expand Oncology Discovery and Translational Research Collaboration

07/14/2009
Kovio Raises $20 Million in Venture Capital to Ship RF Barcodes

07/13/2009
Accuri Cytometers Completes $4 Million Series D Financing

07/07/2009
Helicos BioSciences Announces Publication in Nature Biotechnology

07/07/2009
Humana and BG Medicine Enroll More Than 6,800 Participants in BioImage Study Focused on Heart Attack Prediction

07/07/2009
VisEn Launches New Cat-K FAST™ Fluorescence Molecular Imaging Agent

06/24/2009
TARIS Biomedical Launches with $15 Million in Funding to Develop Innovative Drug-Device Therapies

06/16/2009
The Massachusetts Innovation and Technology Exchange (MITX) announcex that Affinnova received the 2009 Best Marketing Technology Company award

06/02/2009
Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs

05/27/2009
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO

05/19/2009
LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership

05/14/2009
Helicos BioSciences Reports Q1 2009 Financial Results

05/13/2009
AVEO Pharmaceuticals’ Scientific Advisory Board Members Recognized for Contributions to Cancer Research and Medicine

05/11/2009
Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds

05/08/2009
Helicos Demonstrates The Utility of Its Single Molecule Sequencing Platform at Cold Spring Harbor Genome Conference

05/07/2009
Resolvyx Presents Data Demonstrating Potential for Resolvin Therapeutics to Treat Corneal and Retinal Eye Diseases at ARVO 2009 Meeting

05/05/2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel®

05/01/2009
Acceleron Announces Expansion of Cambridge Facilities by Additional 25% During Formal Unveiling of New Corporate Headquarters and Manufacturing Facility

04/20/2009
VisEn Launches Next-Generation Fast (“Fluorescence Activatible Sensor Technology”) Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

04/15/2009
Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class

04/02/2009
SiCortex Announces Record Growth in Q1 2009

04/01/2009
BG Medicine Inc. launches Galectin-3 Website and Commences Galectin-3 Assay Service for Clinical Research

03/24/2009
AVEO and Biogen Idec Form Strategic Alliance for Development and Commercialization of ErbB3-Targeted Antibodies

03/16/2009
Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347

03/12/2009
BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University

03/09/2009
Seahorse Bioscience, Inc. acquires BioProcessors Corp.

03/03/2009
BG Medicine Appoints Doug White as Executive Vice President & General Manager, Diagnostics

02/25/2009
Mascoma Cellulosic Ethanol Plant Begins Operations in Rome, New York

02/25/2009
Genstruct and Gene Logic Collaborate on Systems Toxicology

02/25/2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing

02/17/2009
Oasys Water Closes $10 Million Financing

02/10/2009
Software Industry Veteran Tim Yeaton Named New CEO of Black Duck Software

02/09/2009
Black Duck Software Closes $9.5 Million in Financing

02/04/2009
Helicos Announces Improved Performance of Its HeliScope(TM) Single Molecule Sequencer

01/27/2009
Flagship's Doug Cole named to Mass Life Sciences Center's scientific advisory board

01/13/2009
Ze-gen Secures $20 Million in Funding to Deploy Technology

12/19/2008
Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement

12/18/2008
Terry Newendorp Joins Ze-gen’s Board of Directors

11/24/2008
Agios Pharmaceuticals Expands Into 21,000 SqFt Facility

11/24/2008
Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team

11/20/2008
Resolvyx Announces Open IND for RX-10045, the Lead Resolvin Therapeutic for Dry Eye

11/11/2008
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board

11/06/2008p
SiCortex Responds to Industry Need for Systems-Level Energy Efficiency Data: Proposes Index Based on Balanced Benchmarks

10/27/2008
Concert Pharmaceuticals Announces Preclinical Results Suggesting Potential for Once Daily Dosing of Novel Oxazolidinone Antibiotic

10/24/2008
Mass Technology Leadership Council Announces 2008 Mass Technology Leadership Award Winners

10/20/2008
Novomer Names Industry Veteran Peter Shepard as Vice President of Business Development

10/20/2008
Novomer Set to Continue Strong Momentum with New CEO and Corporate Headquarters in Massachusetts

10/20/2008
T2 Biosystems Appoints Pamela Weagraff as Vice President, Regulatory and Quality

10/17/2008
T2 Biosystems Raises $10.8 Million in Series B Financing

10/17/2008
T2 Biosystems Announces Strategic Investment and Technology Development Agreement with In-Q-Tel

10/16/2008
Kovio Launches World's First Printed Silicon RFID Platform for Item-Level Intelligence

10/08/2008
LS9, Inc. Appoints Bill Haywood Chief Executive Officer

10/07/2008
Mascoma Corporation Announces $49.5 Million in DOE and State of Michigan Funding for Cellulosic Fuel Facility

10/06/2008
Steven Bernitz Joins Concert Pharmaceuticals as Chief Business Officer

09/30/2008
Quanterix Corporation Awarded $185,000 Grant from the National Cancer Institute

09/25/2008
Concert Pharmaceuticals Presents Preclinical Results Supporting Co-Administration of CTP-347 and Tamoxifen

09/23/2008
AVEO Pharmaceuticals Initiates First Clinical Trial of Novel HGF Antagonist in Patients with Advanced Solid Tumors and Lymphomas

09/15/2008
Novomer Recognized by AlwaysOn as GoingGreen Top 100 Winner

08/26/2008
Quanterix Corporation Raises $15 Million in Series A Financing

08/11/2008
Affinnova’s New Client Gains and Increasing Frequency Propel Sales Up 63%

08/06/2008
Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform

08/04/2008
SiCortex, Inc. Names Christopher Stone President and CEO

07/17/2008
BG Medicine Closes $40 Million in Series D Financing

07/08/2008
Codon Devices and Algenol Biofuels Announce Partnership for Development of Biofuels from Algae

07/08/2008
Accuri Cytometers Completes $13 Million Series C Financing

07/07/2008
Agios Pharmaceuticals Closes $33 Million Series A Funding

06/30/2008
Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

06/27/2008
Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

06/24/2008
Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

06/16/2008
Ideal VP Picks for Presidential Candidates to Be Identified With Evolutionary Optimization Software

06/16/2008
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials Of Novel Fluorescence Molecular Imaging Technologies

06/10/2008
Clean Energy Fellowship Program Transitions Proven Entrepreneurs into New England’s Clean Energy Economy

06/03/2008
Interactive Supercomputing Reinforces Management Roster

05/12/2008
Flagship Managing Partner Noubar Afeyan Awarded 2008 Ellis Island Medal of Honor

05/06/2008
Mascoma Corporation Raises $61 Million in Third Round of Funding

05/02/2008
Codon Devices Achieves Milestone in Collaboration with Agrivida in Novel Protein Engineering for Biofuels

05/01/2008
GM and Mascoma Enter into Biofuels Relationship

04/30/2008
Genstruct and Sirtris Pharmaceuticals Win Bio-IT World’s Best Practices Award

04/30/2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing

04/29/2008
Helicos BioSciences Reports Q1 2008 Financial Results

04/28/2008
Black Duck Software Acquires Software Code Search Leader Koders

04/22/2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing

04/22/2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders

04/18/2008
VisEn Medical Raises $5.0 Million in Expanded Series B Financing

04/17/2008
Calling All Experienced Entrepreneurs: New England Clean Energy Council Launches Fellowship Program

04/16/2008
Codon Devices and Merrimack Pharmaceuticals Enter Into Research, Development and License Agreement

04/14/2008
VisEn Medical Launches FMT™ 2500 – Next-Generation Fluorescence Imaging System

04/09/2008
Tetraphase Pharmaceuticals Announces Appointment of Guy Macdonald as President and Chief Executive Officer

04/03/2008
Helicos BioSciences Announces Single Molecule DNA Sequence Data Published in Science Magazine

04/01/2008
Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque

03/31/2008
Codon Devices Secures $11 Million in Series B Financing

03/31/2008
Codon Devices and Blue Heron Biotechnology Announce Settlement of Dispute

03/19/2008
University of Colorado to Use SiCortex Cluster for Space Studies

03/05/2008
Helicos BioSciences Announces Shipment of the World's First Single Molecule DNA Sequencer

02/20/2008
Genstruct Announces New Collaboration with Pfizer in Drug Safety

02/20/2008
Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss

02/12/2008
BG Medicine and Copenhagen General Population Study Initiate Biomarker Discovery to Identify Individuals at High Risk of Heart Attack Within Four Years before Occurrence

02/11/2008
EMD launches first bead-based multiplex assays using EpiTag™ Technology from Epitome Biosystems, Inc.

02/08/2008
Helicos BioSciences Announces First Order for the Helicos™ Genetic Analysis Platform

02/08/2008
Helicos BioSciences Validates Performance of True Single Molecule Sequencing

01/24/2008
GSI Commerce to Acquire e-Dialog

01/23/2008
BG Medicine Announces Decision to Withdraw IPO

01/22/2008
First SC072 Catapult Installed at Rutgers

01/17/2008
Arbor Networks Announces Definitive Agreement To Acquire Ellacoya Networks

01/15/2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing

01/09/2008
Helicos BioSciences Announces MicroRNA Collaboration with miRNA Expert

01/09/2008
Carbon Design Systems Raises $6 Million in Venture Funding After Successful 2007

01/04/2008
Helicos BioSciences Enters into $20 Million Credit Facility with GE Healthcare Financial Services

01/03/2008
T2 Biosystems Appoints John McDonough as CEO

01/03/2008
Codon Devices Names David Smith, Vice President of Operations

01/03/2008
AVEO Pharmaceuticals Appoints Kenneth M. Bate to Board of Directors






© 2009 Flagship Ventures. All rights reserved.